Karolinska Institutet, Department of Neurobiology, Care Sciences and Society, KASPAC, Novum, S-141 57 Huddinge, Sweden.
Neurobiol Aging. 2010 Mar;31(3):409-15. doi: 10.1016/j.neurobiolaging.2008.04.009. Epub 2008 May 22.
The COL25A1 gene, located in 4q25, encodes the CLAC protein, which has been implicated in Alzheimer's disease (AD) pathogenesis. CLAC was originally identified in amyloid preparations from AD brain and has been shown to be associated with amyloid plaques, inhibition of Abeta-fibril elongation and increased protease resistance of Abeta-fibrils through direct binding to Abeta. These biochemical data as well as the genomic location of the COL25A1 gene in chromosome 4q25 where we previously have reported a weak linkage-signal in Swedish AD families encouraged us to perform a case-control association study of two LD blocks in COL25A1 using 817 AD cases and 364 controls. The LD blocks cover a putative Abeta-binding motif and the variable 3' end of the gene. The analyses indicated association to three of eight analysed SNPs. We found further support for the association by replication in a Swedish population-based longitudinal sample set (n=926). Thus, in addition to the biochemical data, there is now genetic evidence of association between COL25A1 and risk for Alzheimer's disease.
COL25A1 基因位于 4q25,编码 CLAC 蛋白,该蛋白与阿尔茨海默病(AD)的发病机制有关。CLAC 最初在 AD 大脑的淀粉样蛋白制剂中被鉴定出来,并且已经显示与淀粉样斑块有关,通过与 Abeta 的直接结合抑制 Abeta 纤维的伸长和增加 Abeta 纤维的蛋白酶抗性。这些生化数据以及 COL25A1 基因在染色体 4q25 上的基因组位置,我们之前在瑞典 AD 家族中报告了一个微弱的连锁信号,这促使我们使用 817 例 AD 病例和 364 例对照进行 COL25A1 中两个 LD 块的病例对照关联研究。LD 块覆盖了一个假定的 Abeta 结合基序和基因的可变 3'端。分析表明与分析的 8 个 SNP 中的 3 个存在关联。我们在瑞典基于人群的纵向样本集(n=926)中进行了复制,进一步证实了这种关联。因此,除了生化数据外,现在还有 COL25A1 与阿尔茨海默病风险之间关联的遗传证据。